Bone markers and cardiovascular risk in type 2 diabetes patients.
dc.contributor.author | Zwakenberg, Sabine R | |
dc.contributor.author | van der Schouw, Yvonne T | |
dc.contributor.author | Schalkwijk, Casper G | |
dc.contributor.author | Spijkerman, Annemieke M W | |
dc.contributor.author | Beulens, Joline W J | |
dc.date.accessioned | 2018-04-19T11:13:02Z | |
dc.date.available | 2018-04-19T11:13:02Z | |
dc.date.issued | 2018-03-23 | |
dc.identifier.citation | Bone markers and cardiovascular risk in type 2 diabetes patients. 2018, 17 (1):45 Cardiovasc Diabetol | en |
dc.identifier.issn | 1475-2840 | |
dc.identifier.pmid | 29571288 | |
dc.identifier.doi | 10.1186/s12933-018-0691-2 | |
dc.identifier.uri | http://hdl.handle.net/10029/621821 | |
dc.description.abstract | Vascular calcifications are associated with a three- to fourfold increased risk of cardiovascular disease (CVD) and are highly prevalent in type 2 diabetes patients. Emerging evidence indicates that vascular calcification is a process of active bone formation regulated by stimulators and inhibitors of calcification. Therefore, this study aimed to evaluate whether six bone markers are associated with CVD risk in patients with type 2 diabetes. | |
dc.language.iso | en | en |
dc.rights | Archived with thanks to Cardiovascular diabetology | en |
dc.title | Bone markers and cardiovascular risk in type 2 diabetes patients. | en |
dc.type | Article | en |
dc.identifier.journal | Cardiovasc Diabetol 2018; 17(1):45 | en |
html.description.abstract | Vascular calcifications are associated with a three- to fourfold increased risk of cardiovascular disease (CVD) and are highly prevalent in type 2 diabetes patients. Emerging evidence indicates that vascular calcification is a process of active bone formation regulated by stimulators and inhibitors of calcification. Therefore, this study aimed to evaluate whether six bone markers are associated with CVD risk in patients with type 2 diabetes. |